Quantbot Technologies LP Invests $1.73 Million in Chemed Corporation $CHE

Quantbot Technologies LP bought a new position in Chemed Corporation (NYSE:CHE) during the 2nd quarter, Holdings Channel.com reports. The institutional investor bought 3,705 shares of the company’s stock, valued at approximately $1,726,000.

Several other large investors also recently made changes to their positions in CHE. Monetary Solutions Ltd bought a new stake in shares of Chemed during the fourth quarter valued at approximately $25,000. Los Angeles Capital Management LLC bought a new position in Chemed in the 4th quarter worth approximately $26,000. BOK Financial Private Wealth Inc. acquired a new stake in Chemed in the 4th quarter valued at approximately $27,000. Mitsubishi UFJ Asset Management Co. Ltd. bought a new stake in Chemed during the 2nd quarter valued at $34,000. Finally, Versant Capital Management Inc raised its stake in Chemed by 7,500.0% during the 2nd quarter. Versant Capital Management Inc now owns 76 shares of the company’s stock valued at $35,000 after acquiring an additional 75 shares in the last quarter. Institutional investors and hedge funds own 95.85% of the company’s stock.

Chemed Trading Down 0.1%

Chemed stock opened at $540.18 on Tuesday. The company has a 50 day moving average price of $501.57 and a 200 day moving average price of $447.26. Chemed Corporation has a 52 week low of $365.20 and a 52 week high of $557.00. The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.89 and a current ratio of 0.91. The firm has a market capitalization of $7.06 billion, a price-to-earnings ratio of 27.13, a P/E/G ratio of 2.05 and a beta of 0.51.

Chemed (NYSE:CHE) last announced its quarterly earnings data on Tuesday, July 28th. The company reported $6.06 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.60 by $0.46. The firm had revenue of $673.25 million during the quarter, compared to the consensus estimate of $665.04 million. Chemed had a return on equity of 31.77% and a net margin of 10.60%.The business’s revenue for the quarter was up 8.8% on a year-over-year basis. During the same period in the prior year, the business earned $4.27 EPS. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. Research analysts forecast that Chemed Corporation will post 23.18 EPS for the current year.

Chemed Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, September 3rd. Stockholders of record on Monday, August 17th will be paid a dividend of $0.70 per share. This is a positive change from Chemed’s previous quarterly dividend of $0.60. The ex-dividend date is Monday, August 17th. This represents a $2.80 annualized dividend and a dividend yield of 0.5%. Chemed’s dividend payout ratio (DPR) is currently 14.06%.

Insider Buying and Selling at Chemed

In other Chemed news, Director Patrick P. Grace sold 190 shares of the stock in a transaction that occurred on Friday, July 31st. The stock was sold at an average price of $532.00, for a total transaction of $101,080.00. Following the transaction, the director owned 3,533 shares in the company, valued at $1,879,556. This trade represents a 5.10% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, EVP Spencer S. Lee sold 1,000 shares of Chemed stock in a transaction on Friday, August 21st. The stock was sold at an average price of $541.04, for a total transaction of $541,040.00. Following the completion of the transaction, the executive vice president owned 13,912 shares in the company, valued at $7,526,948.48. This trade represents a 6.71% decrease in their position. The SEC filing for this sale provides additional information. In the last 90 days, insiders have sold 6,537 shares of company stock worth $3,406,014. Company insiders own 3.33% of the company’s stock.

Analysts Set New Price Targets

Several research firms have recently issued reports on CHE. Zacks Research raised Chemed from a “strong sell” rating to a “hold” rating in a research note on Monday, April 27th. Royal Bank Of Canada lifted their price objective on shares of Chemed from $436.00 to $548.00 and gave the company a “sector perform” rating in a research note on Thursday, July 30th. Wall Street Zen raised shares of Chemed from a “hold” rating to a “strong-buy” rating in a report on Saturday, August 1st. Weiss Ratings upgraded shares of Chemed from a “hold (c-)” rating to a “hold (c)” rating in a research report on Friday, July 17th. Finally, Oppenheimer raised their target price on shares of Chemed from $500.00 to $590.00 and gave the company an “outperform” rating in a research note on Friday, July 31st. One research analyst has rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $530.75.

Chemed Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.